Adverse events associated with encorafenib plus binimetinib in the COLUMBUS study: incidence, course and management. [electronic resource]
Producer: 20200608Description: 97-106 p. digitalISSN:- 1879-0852
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Benzimidazoles -- administration & dosage
- Carbamates -- administration & dosage
- Fatigue -- chemically induced
- Female
- Humans
- Incidence
- Male
- Melanoma -- drug therapy
- Middle Aged
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Mutation
- Nausea -- chemically induced
- Protein Kinase Inhibitors -- administration & dosage
- Proto-Oncogene Proteins B-raf -- antagonists & inhibitors
- Skin Neoplasms -- drug therapy
- Sulfonamides -- administration & dosage
- Vemurafenib -- administration & dosage
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.